Physician profile
Mark E Hamilton
NPI 1447246541
$350,938.57
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127K · 2020: $72K · 2021: $61K · 2022: $63K · 2023: $26K · 2024: $1,575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Consulting Fee: $9,225 · Travel and Lodging: $1,653 · Food and Beverage: $1,034.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,500.00 |
| Consulting Fee | $9,225.00 |
| Travel and Lodging | $1,652.59 |
| Food and Beverage | $1,034.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $91,673.77 | 2019-2024 | Pinnacle, Corail, Attune |
| Mallinckrodt Enterprises LLC | $81,623.13 | 2019 | |
| Medtronic, INC. | $69,270.60 | 2021-2023 | Aquamantys(Tm), Plasmablade(Tm) |
| Medtronic USA, INC. | $62,154.09 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $22,436.91 | 2019-2023 | Exparel |
| Mallinckrodt Hospital Products INC. | $22,112.06 | 2020 | |
| Pacira Therapeutics, INC. | $800.00 | 2021 | |
| Depuy Synthes Sales INC. | $588.07 | 2019-2021 | |
| Heron Therapeutics, INC. | $115.86 | 2022 | |
| Baudax Bio INC. | $79.57 | 2020 | |
| Novartis Pharmaceuticals Corporation | $49.00 | 2019 | |
| Inari Medical, INC. | $35.51 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hamilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.